XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
shares in Millions, $ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Total Ingersoll Rand Inc. Stockholders' Equity
Total Ingersoll Rand Inc. Stockholders' Equity
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Capital in Excess of Par Value
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Treasury Stock
Noncontrolling Interests
Balance at beginning of period (in shares) at Dec. 31, 2019         206.8            
Balance at beginning of period at Dec. 31, 2019 $ 1,869.9 $ (1.0) $ 1,869.9 $ (1.0) $ 2.1 $ 2,302.0 $ (141.4) $ (1.0) $ (256.0) $ (36.8) $ 0.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income (loss) (213.4)   (214.4)       (214.4)       1.0
Acquisition of Ingersoll Rand Industrial (in shares)         211.0            
Acquisition of Ingersoll Rand Industrial 7,009.3   6,937.0   $ 2.1 6,934.9         72.3
Costs of issuing equity securities (1.0)   (1.0)     (1.0)          
Issuance of common stock for stock-based compensation plans (in shares)         0.8            
Issuance of common stock for stock-based compensation plans 5.9   5.9     5.9          
Purchases of treasury stock (1.3)   (1.3)             (1.3)  
Issuance of treasury stock for stock-based compensation plans 0.8   0.8     (1.5)       2.3  
Stock-based compensation 16.2   16.2     16.2          
Other comprehensive income (loss), net of tax (41.6)   (37.2)           (37.2)   (4.4)
Adjustments for shares tendered in open offer 2.0                   2.0
Balance at end of period (in shares) at Jun. 30, 2020         418.6            
Balance at end of period at Jun. 30, 2020 8,641.8   8,574.9   $ 4.2 9,256.5 (356.8)   (293.2) (35.8) 66.9
Balance at beginning of period (in shares) at Mar. 31, 2020         418.2            
Balance at beginning of period at Mar. 31, 2020 8,755.5   8,686.2   $ 4.2 9,241.5 (179.2)   (344.1) (36.2) 69.3
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income (loss) (176.5)   (177.6)       (177.6)       1.1
Issuance of common stock for stock-based compensation plans (in shares)         0.4            
Issuance of common stock for stock-based compensation plans 3.7   3.7     3.7          
Purchases of treasury stock (0.5)   (0.5)             (0.5)  
Issuance of treasury stock for stock-based compensation plans 0.4   0.4     (0.5)       0.9  
Stock-based compensation 11.8   11.8     11.8          
Other comprehensive income (loss), net of tax 49.4   50.9           50.9   (1.5)
Adjustments for shares tendered in open offer 2.0                   2.0
Balance at end of period (in shares) at Jun. 30, 2020         418.6            
Balance at end of period at Jun. 30, 2020 8,641.8   8,574.9   $ 4.2 9,256.5 (356.8)   (293.2) (35.8) 66.9
Balance at beginning of period (in shares) at Dec. 31, 2020         420.1            
Balance at beginning of period at Dec. 31, 2020 9,189.5   9,119.7   $ 4.2 9,310.3 (175.7)   14.2 (33.3) 69.8
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income (loss) 144.5   143.5       143.5       1.0
Issuance of common stock for stock-based compensation plans (in shares)         1.4            
Issuance of common stock for stock-based compensation plans 12.3   12.3     12.3          
Purchases of treasury stock (3.2)   (3.2)             (3.2)  
Issuance of treasury stock for stock-based compensation plans 0.8   0.8     (1.1)       1.9  
Stock-based compensation 54.5   54.5     54.5          
Other comprehensive income (loss), net of tax (50.5)   (48.2)           (48.2)   (2.3)
Divestiture of foreign subsidiaries (1.5)   (1.5)           (1.5)    
Balance at end of period (in shares) at Jun. 30, 2021         421.5            
Balance at end of period at Jun. 30, 2021 9,346.4   9,277.9   $ 4.2 9,376.0 (32.2)   (35.5) (34.6) 68.5
Balance at beginning of period (in shares) at Mar. 31, 2021         420.9            
Balance at beginning of period at Mar. 31, 2021 9,025.7   8,956.7   $ 4.2 9,337.8 (266.1)   (84.4) (34.8) 69.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income (loss) 234.6   233.9       233.9       0.7
Issuance of common stock for stock-based compensation plans (in shares)         0.6            
Issuance of common stock for stock-based compensation plans 7.6   7.6     7.6          
Purchases of treasury stock (0.2)   (0.2)             (0.2)  
Issuance of treasury stock for stock-based compensation plans 0.4   0.4             0.4  
Stock-based compensation 30.6   30.6     30.6          
Other comprehensive income (loss), net of tax 49.2   50.4           50.4   (1.2)
Divestiture of foreign subsidiaries (1.5)   (1.5)           (1.5)    
Balance at end of period (in shares) at Jun. 30, 2021         421.5            
Balance at end of period at Jun. 30, 2021 $ 9,346.4   $ 9,277.9   $ 4.2 $ 9,376.0 $ (32.2)   $ (35.5) $ (34.6) $ 68.5